Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients.

被引：0
|
作者：
Wang, Z. [1 ]
Han, Z. [1 ]
Tao, J. [1 ]
Chen, H. [1 ]
Sun, L. [1 ]
Tan, R. [1 ]
Gu, M. [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Urol, Nanjing, Jiangsu, Peoples R China
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2018年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B125
引用
收藏
页码：672 / 672
页数：1
相关论文
共 50 条
  • [1] Pharmacogenetics of CYP3A4, CYP3A5, CYP2C8 and CYP2C19 and Their Influence on Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Li, Sun
    Tan, Ruoyun
    Gu, Min
    TRANSPLANTATION, 2018, 102 : S281 - S281
  • [2] Association of Genetic Variants in CYP3A4, CYP3A5, CYP2C8, and CYP2C19 with Tacrolimus Pharmacokinetics in Renal Transplant Recipients
    Wang, Zijie
    Zheng, Ming
    Yang, Haiwei
    Han, Zhijian
    Tao, Jun
    Chen, Hao
    Sun, Li
    Guo, Miao
    Wang, Libin
    Tan, Ruoyun
    Wei, Ji-Fu
    Gu, Min
    CURRENT DRUG METABOLISM, 2019, 20 (07) : 609 - 618
  • [3] Response to "Pharmacogenetics of Voriconazole: CYP2C19 but Also CYP3A4 Need to Be Genotyped" - The Role of CYP3A4 and CYP3A5 Polymorphisms in Clinical Pharmacokinetics of Voriconazole
    Walsh, T. J.
    Moriyama, B.
    Penzak, S. R.
    Klein, T. E.
    Caudle, K. E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 102 (02) : 190 - 190
  • [4] Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
    Henningsson, A
    Marsh, S
    Loos, WJ
    Karlsson, MO
    Garsa, A
    Mross, K
    Mielke, S
    Viganò, L
    Locatelli, A
    Verweij, J
    Sparreboom, A
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8097 - 8104
  • [5] CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast
    Karonen, Tiina
    Neuvonen, Pertti J.
    Backman, Janne T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 73 (02) : 257 - 267
  • [6] Influence of CYP2C8, CYP3A4, and CYP3A5 Host Genotypes on Early Recurrence of Plasmodium vivax
    Almeida, Anne C. G.
    Puca, Maria C. B.
    Figueiredo, Erick F. G.
    Barbosa, Laila R.
    Salazar, Yanka E. A. R.
    Silva, Emanuelle L.
    Brito, Marcelo A. M.
    Siqueira, Andre M.
    Vieira, Jose L. F.
    Lacerda, Marcus V. G.
    Monteiro, Wuelton M.
    Melo, Gisely C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (07)
  • [7] Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Kohlrausch, Fabiana B.
    Carracedo, Angel
    Hutz, Mara H.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (03) : 1453 - 1460
  • [8] Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
    Fabiana B. Kohlrausch
    Ángel Carracedo
    Mara H. Hutz
    Molecular Biology Reports, 2014, 41 : 1453 - 1460
  • [9] Effect of genetic variants in CYP2C8, CYP3A4, CYP3A5, and ABCB1 on paclitaxel pharmacokinetics.
    Sparreboom, A
    Marsh, S
    Henningsson, A
    Karlsson, MO
    Garsa, A
    Loos, WJ
    Verweij, J
    McLeod, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 139S - 139S
  • [10] INFLUENCE OF CYP2C19 AND CYP3A4 ON TILIDINE PHARMACOKINETICS AND METABOLISM IN HUMANS
    Merkel, U.
    Riedel, K. -D.
    Gruen, B.
    Mikus, G.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 22 - 22
12345